Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 1499-1503, March 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manchester, D. K.
Right arrow Articles by Weston, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manchester, D. K.
Right arrow Articles by Weston, A.

Determinants of Polycyclic Aromatic Hydrocarbon-DNA Adducts in Human Placenta1

David K. Manchester, Elise D. Bowman, Natalie B. Parker, Neil E. Caporaso and Ainsley Weston2

The Children's Hospital Kempe Research Center, Department of Pediatrics and Pharmacology, University of Colorado School of Medicine, Denver, Colorado 80218 [D. K. M., N. B. P.], and Laboratory of Human Carcinogenesis [E. D. B., A. W.] and Environmental Epidemiology Branch [N. E. C.], National Cancer Institute, NIH, Bethesda, Maryland 20892

To determine the relative contributions of tobacco smoking and P-450 metabolism (cytochrome P-450IAI) in the formation of benzo(a)pyrenediol-epoxide and other polycyclic aromatic hydrocarbon-DNA adducts in vivo, 16 human placentas were assayed for aryl hydrocarbon hydroxylase activity and (±)r-7,t-8-dihydroxy-c-9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene-DNA adduct levels. Immunoaffinity chromatography columns, conjugated with monoclonal antibodies raised against benzo(a)-pyrene-diol-epoxide-deoxyguanosine, were used to concentrate polycyclic aromatic hydrocarbon-DNA adducted nucleotides, and synchronous fluorescence spectroscopy was used specifically to detect r-7,t-8,t-9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo(a)pyrene (BP-tetrol) extracted from acid hydrolysates of immunoconcentrated materials. Data were analyzed for associations with maternal dietary and smoking habits, umbilical cord blood cotinine levels, and placental aryl hydrocarbon hydroxylase levels. Complex mixtures of fluorescent materials were present in organic solvent extracts of acid hydrolysates of immunoconcentrated nucleotide-adducts from all placentas with patterns of fluorescence that may be associated with tobacco smoking determined by generation of spectral fluorescence excitation-emission matrices. BP-tetrols were detected in extracts from 8 placentas: 5 of 7 from smokers and 3 of 9 from nonsmokers. Placental aryl hydrocarbon hydroxylase activity was significantly higher in placentas from which BP-tetrols were extracted [13.0 ± 4.0 (mean ± SE) pmol 3-hydroxybenzo(a)pyrene mg protein–1 min–1], than among placentas from which BP-tetrols were not extracted (1.3 ± 3.7 pmol 3-hydroxybenzo(a)pyrene mg protein–1 min–1) (P = 0.03, Student's t test). This association was independent of maternal smoking or umbilical cord blood cotinine levels. These results indicate that while maternal tobacco smoking is associated with the accumulation of putative, but as yet unidentified, polycyclic aromatic hydrocarbon-DNA adducts in placenta, metabolic capacity appears to be the principal determinant for the (±)r-7,t-8-dihydroxy-c-9,10 epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene-DNA adduct levels detected.

1 This work was supported, in part, by the March of Dimes Reproductive Hazards in the Workplace, Home and Environment, Grant 17–115; and by a grant (RR-69) from the General Clinical Research Centers Program of the Division of Research Resources, NIH.

2 To whom requests for reprints should be addressed, at: Room 2C16, Building 37, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

Received 9/18/91. Accepted 1/ 8/92.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
D. H. Phillips
Smoking-related DNA and protein adducts in human tissues
Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. M. Gressani, S. Leone-Kabler, M.G. O'Sullivan, L.D. Case, A. M. Malkinson, and M. S. Miller
Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene
Carcinogenesis, November 1, 1999; 20(11): 2159 - 2165.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. M. Lackmann, U. Salzberger, U. Tollner, M. Chen, S. G. Carmella, and S. S. Hecht
Metabolites of a Tobacco-Specific Carcinogen in Urine From Newborns
J Natl Cancer Inst, March 3, 1999; 91(5): 459 - 465.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.